279 related articles for article (PubMed ID: 18248624)
1. Parkin mediates the degradation-independent ubiquitination of Hsp70.
Moore DJ; West AB; Dikeman DA; Dawson VL; Dawson TM
J Neurochem; 2008 Jun; 105(5):1806-19. PubMed ID: 18248624
[TBL] [Abstract][Full Text] [Related]
2. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
[TBL] [Abstract][Full Text] [Related]
3. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
[TBL] [Abstract][Full Text] [Related]
4. Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1.
Glauser L; Sonnay S; Stafa K; Moore DJ
J Neurochem; 2011 Aug; 118(4):636-45. PubMed ID: 21615408
[TBL] [Abstract][Full Text] [Related]
5. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.
Lim MK; Kawamura T; Ohsawa Y; Ohtsubo M; Asakawa S; Takayanagi A; Shimizu N
Exp Cell Res; 2007 Aug; 313(13):2858-74. PubMed ID: 17512523
[TBL] [Abstract][Full Text] [Related]
6. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.
Xiong H; Wang D; Chen L; Choo YS; Ma H; Tang C; Xia K; Jiang W; Ronai Z; Zhuang X; Zhang Z
J Clin Invest; 2009 Mar; 119(3):650-60. PubMed ID: 19229105
[TBL] [Abstract][Full Text] [Related]
7. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
9. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
10. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function.
Tsai YC; Fishman PS; Thakor NV; Oyler GA
J Biol Chem; 2003 Jun; 278(24):22044-55. PubMed ID: 12676955
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
[TBL] [Abstract][Full Text] [Related]
12. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.
Romaní-Aumedes J; Canal M; Martín-Flores N; Sun X; Pérez-Fernández V; Wewering S; Fernández-Santiago R; Ezquerra M; Pont-Sunyer C; Lafuente A; Alberch J; Luebbert H; Tolosa E; Levy OA; Greene LA; Malagelada C
Cell Death Dis; 2014 Aug; 5(8):e1364. PubMed ID: 25101677
[TBL] [Abstract][Full Text] [Related]
13. Parkin: a multifaceted ubiquitin ligase.
Moore DJ
Biochem Soc Trans; 2006 Nov; 34(Pt 5):749-53. PubMed ID: 17052189
[TBL] [Abstract][Full Text] [Related]
14. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and Proteomic Analysis of Ubiquitination of Hsc70 and Hsp70 by the E3 Ligase CHIP.
Soss SE; Rose KL; Hill S; Jouan S; Chazin WJ
PLoS One; 2015; 10(5):e0128240. PubMed ID: 26010904
[TBL] [Abstract][Full Text] [Related]
16. Parkin ubiquitinates and promotes the degradation of RanBP2.
Um JW; Min DS; Rhim H; Kim J; Paik SR; Chung KC
J Biol Chem; 2006 Feb; 281(6):3595-603. PubMed ID: 16332688
[TBL] [Abstract][Full Text] [Related]
17. BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.
Kalia SK; Lee S; Smith PD; Liu L; Crocker SJ; Thorarinsdottir TE; Glover JR; Fon EA; Park DS; Lozano AM
Neuron; 2004 Dec; 44(6):931-45. PubMed ID: 15603737
[TBL] [Abstract][Full Text] [Related]
18. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.
Zhang Y; Gao J; Chung KK; Huang H; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13354-9. PubMed ID: 11078524
[TBL] [Abstract][Full Text] [Related]
19. Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting.
Williams ET; Glauser L; Tsika E; Jiang H; Islam S; Moore DJ
Hum Mol Genet; 2018 Sep; 27(18):3189-3205. PubMed ID: 29893854
[TBL] [Abstract][Full Text] [Related]
20. A molecular explanation for the recessive nature of parkin-linked Parkinson's disease.
Spratt DE; Martinez-Torres RJ; Noh YJ; Mercier P; Manczyk N; Barber KR; Aguirre JD; Burchell L; Purkiss A; Walden H; Shaw GS
Nat Commun; 2013; 4():1983. PubMed ID: 23770917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
